SC
PFE icon

Swan Capital’s Pfizer PFE Stock Holding History

Swan Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$330K Buy
11,754
+435
+4% +$11.6K 0.12% 33
2025
Q4 		$282K Sell
11,319
-50
-0.4% -$1.26K 0.11% 35
2025
Q3 		$290K Buy
11,369
+2
+0% +$49 0.12% 34
2025
Q2 		$276K Buy
11,367
+1
+0% +$23 0.12% 37
2025
Q1 		$288K Buy
11,366
+1
+0% +$26 0.13% 32
2024
Q4 		$302K Buy
11,365
+263
+2% +$7.13K 0.15% 30
2024
Q3 		$321K Hold
11,102
– – 0.16% 30
2024
Q2 		$311K Buy
11,102
+28
+0.3% +$771 0.17% 30
2024
Q1 		$307K Buy
11,074
+272
+3% +$7.55K 0.17% 30
2023
Q4 		$311K Buy
10,802
+464
+4% +$14K 0.2% 26
2023
Q3 		$343K Buy
+10,338
New +$366K 0.27% 25

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Swan Capital's PFE Position: Q1 2026 in Review

Swan Capital increased its Pfizer (PFE) stake by 3.8% in Q1 2026, buying an estimated $11.6K and bringing the position to 11,754 shares worth $330K. The position accounts for 0.12% of the portfolio, ranked #33.

Swan Capital first reported a position in PFE in Q3 2023 and has held it in 11 quarters since. The position peaked at $343K in Q3 2023. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Swan Capital held 11,754 shares of Pfizer worth $330K as of Q1 2026.
  • Swan Capital bought 435 Pfizer shares in Q1 2026, an estimated $11.6K.
  • Pfizer made up 0.12% of Swan Capital's portfolio in Q1 2026, its #33 holding.
  • Swan Capital first reported a position in Pfizer in Q3 2023 and has held it in 11 quarters since.
  • Swan Capital's Pfizer position peaked at $343K in Q3 2023.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Swan Capital's 13F filing for Q1 2026, filed 14 May 2026.